Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment
Authors
Keywords
O-1918, TNBS-colitis, Wound healing, Neutrophil recruitment, Cannabinoids, Abnormal cannabidiol
Journal
Journal of Inflammation-London
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-24
DOI
10.1186/s12950-016-0129-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple Roles for Neutrophils in Atherosclerosis
- (2012) Oliver Soehnlein CIRCULATION RESEARCH
- Inflammatory bowel disease: an impaired barrier disease
- (2012) Simon Jäger et al. LANGENBECKS ARCHIVES OF SURGERY
- Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice
- (2012) Rudolf Schicho et al. PHARMACOLOGY
- Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
- (2011) George W. Booz FREE RADICAL BIOLOGY AND MEDICINE
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
- (2010) Douglas McHugh et al. BMC NEUROSCIENCE
- GPR55 ligands promote receptor coupling to multiple signalling pathways
- (2010) Christopher M Henstridge et al. BRITISH JOURNAL OF PHARMACOLOGY
- The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment
- (2010) Rudolf Schicho et al. INFLAMMATORY BOWEL DISEASES
- Cannabinoids and the gut: New developments and emerging concepts
- (2010) Angelo A. Izzo et al. PHARMACOLOGY & THERAPEUTICS
- Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis
- (2009) Martin A. Storr et al. INFLAMMATORY BOWEL DISEASES
- Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
- (2009) Francesca Borrelli et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cannabinoids in intestinal inflammation and cancer
- (2009) Angelo A. Izzo et al. PHARMACOLOGICAL RESEARCH
- 2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells
- (2008) Susanne Kreutz et al. GLIA
- Modulation of the Endocannabinoid System in Cardiovascular Disease
- (2008) Pál Pacher et al. HYPERTENSION
- Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment
- (2008) Maria Lampinen et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Epithelial restitution and wound healing in inflammatory bowel disease
- (2008) Andreas Sturm et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
- (2007) D G Johns et al. BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now